Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients
2008

Evaluating Unclassified Variants in BRCA1 and BRCA2 Genes in Young Breast Cancer Patients

Sample size: 1469 publication Evidence: moderate

Author Information

Author(s): Lee Eunjung, McKean-Cowdin Roberta, Ma Huiyan, Chen Zhengjia, Van Den Berg David, Henderson Brian E, Bernstein Leslie, Ursin Giske

Primary Institution: Keck School of Medicine, University of Southern California

Hypothesis

Do women carrying unclassified variants in BRCA1/BRCA2 have characteristics similar to those with known deleterious mutations?

Conclusion

The study found that classification methods for unclassified variants yielded similar results, particularly highlighting the effectiveness of the Polyphen algorithm for identifying high-risk BRCA1 carriers.

Supporting Evidence

  • Identified 262 distinct BRCA1/BRCA2 variants, including 147 unclassified variants.
  • High-risk BRCA1 unclassified variant carriers had a higher family history of breast cancer.
  • Polyphen algorithm was particularly effective in identifying high-risk BRCA1 carriers.

Takeaway

Scientists looked at genes that might cause breast cancer in young women and found ways to tell if some changes in these genes are risky or not.

Methodology

Sequenced BRCA1/BRCA2 in 1,469 female breast cancer patients aged 20-49 and classified variants using five methods.

Limitations

The study's narrow age range and exclusion of certain patients may limit the generalizability of the findings.

Participant Demographics

Female breast cancer patients aged 20-49, primarily white and African-American.

Statistical Information

P-Value

0.012

Confidence Interval

1.16 to 9.94

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1865

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication